Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
about
Metabolic consequences of modern immunosuppressive agents in solid organ transplantationKidney transplant after hematopoietic cell transplant in pediatrics: Infectious and immunosuppressive considerations.Donation after brain death followed by circulatory death, a novel donation pattern, confers comparable renal allograft outcomes with donation after brain death.Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians
P2860
Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Efficacy and safety of thymogl ...... on and delayed graft function.
@ast
Efficacy and safety of thymogl ...... on and delayed graft function.
@en
type
label
Efficacy and safety of thymogl ...... on and delayed graft function.
@ast
Efficacy and safety of thymogl ...... on and delayed graft function.
@en
prefLabel
Efficacy and safety of thymogl ...... on and delayed graft function.
@ast
Efficacy and safety of thymogl ...... on and delayed graft function.
@en
P2093
P356
P1476
Efficacy and safety of thymogl ...... on and delayed graft function.
@en
P2093
Changxi Wang
Gang Huang
Guodong Chen
Jiguang Fei
Lizhong Chen
Suxiong Deng
P304
P356
10.6002/ECT.2012.0103
P577
2012-11-01T00:00:00Z